The MarketReader Minute
💊 Biotech Sector Insights | ABBV +1.3%
Key contributors like AMGN and BIIB had notable returns. Abbvie Inc's stock showed positive movement after releasing encouraging results from the Phase 2 PICCOLO Trial and MRNA's stock rose significantly as the company's mRNA-3705 drug candidate was selected for an FDA pilot program.